These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 26538397

  • 1. FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain.
    Sundararaj KP, Thiyagarajan T, Molano I, Basher F, Powers TW, Drake RR, Nowling TK.
    J Immunol; 2015 Dec 15; 195(12):5551-60. PubMed ID: 26538397
    [Abstract] [Full Text] [Related]

  • 2. Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.
    Richard EM, Thiyagarajan T, Bunni MA, Basher F, Roddy PO, Siskind LJ, Nietert PJ, Nowling TK.
    PLoS One; 2013 Dec 15; 8(9):e75175. PubMed ID: 24040398
    [Abstract] [Full Text] [Related]

  • 3. Role of the transcription factor Fli-1 on the CXCL10/CXCR3 Axis.
    Wang X, Richard ML, Caldwell TS, Sundararaj K, Sato S, Nowling TK, Zhang XK.
    Front Immunol; 2023 Dec 15; 14():1219279. PubMed ID: 37790939
    [Abstract] [Full Text] [Related]

  • 4. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 5. The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.
    Sato S, Zhang XK.
    Clin Exp Immunol; 2014 Jul 01; 177(1):102-9. PubMed ID: 24580413
    [Abstract] [Full Text] [Related]

  • 6. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
    Nowling TK, Rodgers J, Thiyagarajan T, Wolf B, Bruner E, Sundararaj K, Molano I, Gilkeson G.
    PLoS One; 2020 Jul 01; 15(3):e0230499. PubMed ID: 32187230
    [Abstract] [Full Text] [Related]

  • 7. Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis.
    Sato S, Zhang XK, Temmoku J, Fujita Y, Matsuoka N, Yashiro-Furuya M, Asano T, Kobayashi H, Watanabe H, Migita K.
    Cells; 2020 Mar 14; 9(3):. PubMed ID: 32183259
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X.
    Front Immunol; 2021 Mar 14; 12():584414. PubMed ID: 33717066
    [Abstract] [Full Text] [Related]

  • 9. ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.
    Odegard JM, DiPlacido LD, Greenwald L, Kashgarian M, Kono DH, Dong C, Flavell RA, Craft J.
    J Immunol; 2009 Apr 01; 182(7):4076-84. PubMed ID: 19299705
    [Abstract] [Full Text] [Related]

  • 10. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr 01; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 11. Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis.
    Nowling TK, Mather AR, Thiyagarajan T, Hernández-Corbacho MJ, Powers TW, Jones EE, Snider AJ, Oates JC, Drake RR, Siskind LJ.
    J Am Soc Nephrol; 2015 Jun 01; 26(6):1402-13. PubMed ID: 25270066
    [Abstract] [Full Text] [Related]

  • 12. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
    Menke J, Zeller GC, Kikawada E, Means TK, Huang XR, Lan HY, Lu B, Farber J, Luster AD, Kelley VR.
    J Am Soc Nephrol; 2008 Jun 01; 19(6):1177-89. PubMed ID: 18337479
    [Abstract] [Full Text] [Related]

  • 13. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.
    Sato S, Zhang XK, Matsuoka N, Sumichika Y, Saito K, Yoshida S, Matsumoto H, Temmoku J, Fujita Y, Asano T, Migita K.
    Lupus Sci Med; 2023 Apr 01; 10(1):. PubMed ID: 37094946
    [Abstract] [Full Text] [Related]

  • 14. CXCR3-deficient mesenchymal stem cells fail to infiltrate into the nephritic kidney and do not ameliorate lupus symptoms in MRL. Faslpr mice.
    Lee JH, Lee HK, Kim HS, Kim JS, Ji AY, Lee JS, Kim KS, Lee TY, Bae SC, Kim Y, Hong JT, Han SB.
    Lupus; 2018 Oct 01; 27(11):1854-1859. PubMed ID: 30139297
    [Abstract] [Full Text] [Related]

  • 15. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A.
    Arthritis Rheum; 2002 Nov 01; 46(11):3083-95. PubMed ID: 12428253
    [Abstract] [Full Text] [Related]

  • 16. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
    Hamar P, Wang M, Godo M, Kokeny G, Rosivall L, Ouyang N, Heemann U.
    Lupus; 2010 Feb 01; 19(2):175-81. PubMed ID: 19946036
    [Abstract] [Full Text] [Related]

  • 17. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Tesch G, Kinoshita K, Maron R, Weiner HL, Kelley VR.
    J Immunol; 1999 Dec 15; 163(12):6884-91. PubMed ID: 10586090
    [Abstract] [Full Text] [Related]

  • 18. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice.
    Zhang XK, Gallant S, Molano I, Moussa OM, Ruiz P, Spyropoulos DD, Watson DK, Gilkeson G.
    J Immunol; 2004 Nov 15; 173(10):6481-9. PubMed ID: 15528390
    [Abstract] [Full Text] [Related]

  • 19. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.
    J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 15; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.